A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Neonc Technologies, Inc.
University of Pittsburgh
Incyte Corporation
Incyte Corporation
Children's National Research Institute
Xencor, Inc.
M.D. Anderson Cancer Center
Stanford University
Incyte Corporation
National Cancer Institute (NCI)
Threshold Pharmaceuticals